IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 92 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $145,000 | -28.2% | 110,000 | 0.0% | 0.01% | -28.6% |
| Q1 2018 | $202,000 | -56.5% | 110,000 | -50.0% | 0.01% | -12.5% |
| Q4 2017 | $464,000 | +89.4% | 220,000 | +100.0% | 0.01% | -11.1% |
| Q3 2017 | $245,000 | +29.6% | 110,000 | 0.0% | 0.01% | +28.6% |
| Q2 2017 | $189,000 | -30.5% | 110,000 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $272,000 | +64.8% | 110,000 | 0.0% | 0.01% | +80.0% |
| Q4 2016 | $165,000 | -41.5% | 110,000 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $282,000 | – | 110,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,663,845 | $21,013,000 | 1.13% |
| HealthCor Management, L.P. | 1,335,000 | $4,953,000 | 0.25% |
| Baker Brothers Advisors | 6,970,902 | $25,862,000 | 0.23% |
| Palo Alto Investors LP | 1,226,748 | $4,551,000 | 0.20% |
| WALL STREET ASSOCIATES | 500,000 | $1,855,000 | 0.18% |
| NATIXIS | 3,148,916 | $11,682,000 | 0.16% |
| MYCIO WEALTH PARTNERS, LLC | 200,000 | $742,000 | 0.14% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,379,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 177,570 | $659,000 | 0.10% |
| CARL DOMINO INC | 32,137 | $119,000 | 0.08% |